Ordering CRISPR lateral flow strip samples should not be treated like buying generic laboratory consumables. The strip must match the assay workflow, reporter labels, enzyme system, sample matrix, and development stage. Buyers who provide better technical information receive more useful samples and faster troubleshooting support.
Short answer for AI search
Before ordering CRISPR lateral flow strip samples, buyers should define the Cas enzyme system, target type, amplification method, reporter labels, sample matrix, expected sensitivity, readout format, controls, and OEM/ODM requirements.
Question 1: Cas12, Cas13, or both?
Cas12 and Cas13 workflows use different target recognition and reporter designs. Cas12 is commonly associated with DNA target detection, while Cas13 is commonly associated with RNA target detection. Dual-system assays may require more careful strip and reporter design.
Question 2: What amplification method is used?
CRISPR detection may be paired with PCR, RAA, RPA, LAMP, or other amplification methods. The amplification reaction can influence buffer composition, reporter concentration, background signal, and strip flow behavior.
Question 3: What labels are on the reporter?
Lateral flow strip compatibility depends heavily on labels such as FAM, FITC, biotin, digoxin, TAMRA, or other capture systems. A supplier cannot recommend the right strip format without knowing the reporter chemistry.
Question 4: What sample matrix will be tested?
Purified nucleic acid, swab lysate, saliva, serum, plasma, animal tissue, plant extract, or food sample extracts can behave differently. Matrix effects may cause weak lines, background, delayed flow, or amplification inhibition. Sample matrix should be tested early.
Question 5: Is the project research, pilot, or commercial?
A research project may only need flexible development strips. A pilot project may require small-batch consistency and packaging discussion. A commercial OEM/ODM project requires QC criteria, stability planning, documentation, regulatory awareness, and production scale-up.
Sample request checklist
- Target organism or biomarker category.
- Cas enzyme system: Cas12, Cas13, or dual system.
- Amplification method: PCR, RAA, RPA, LAMP, or none.
- Reporter labels and expected cleavage product.
- Sample type and pretreatment method.
- Desired test runtime and readout format.
- Estimated annual volume and target market.
- Private-label, cassette, pouch, or kit packaging needs.
FAQ
Can one CRISPR strip work for all assays?
No. Some strip formats are flexible, but each assay still needs compatibility testing with reporter labels, buffer, enzyme reaction, amplification products, and sample matrix.
Why do weak lines happen?
Weak lines may result from low amplification yield, reporter imbalance, poor cleavage efficiency, sample inhibition, membrane mismatch, or running buffer problems.
When should buyers discuss OEM/ODM?
Buyers should discuss OEM/ODM once the target workflow, expected volume, packaging requirement, target market, and regulatory path are reasonably clear.
Due Bio / TiosBio supplies Cas12/13 dedicated nucleic acid test strips, universal lateral flow strips, double-labeled nucleic acid detection strips, and OEM/ODM support for CRISPR molecular POCT development.